Top 10 Clinical Trends for June 2015

Ryan Syrek

Disclosures

June 24, 2015

#6 Clinical Trend: Hypertriglyceridemia

The Amarin Corporation PLC is developing a product, AMR101, that is an ultra-pure omega-3 fatty acid designed to treat hypertriglyceridemia. The company recently released an earnings report that included information about the upcoming product. Physicians are clearly interested in a new potential tool to treat this condition.

For more in-depth clinical information, see Hypertriglyceridemia.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....